Back to companies

IPI Legacy Liquidation Co: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

IPI Legacy Liquidation Co (IPI Legacy Liquidation), formerly Impel Pharmaceuticals Inc, is a clinical-stage biotechnology company that develops and commercializes transformative therapies for patients suffering from diseases with high unmet medical needs. Its product includes Trudhesa, a dihydroergotamine mesylate nasal spray approved for the acute treatment of migraine in adults. It utilizes Precision Olfactory Delivery (POD) technology to develop drugs. IPI Legacy Liquidation products are primarily used by patients suffering from migraines. IPI Legacy Liquidation is headquartered in Seattle, Washington, the US.

Gain a 360-degree view of IPI Legacy Liquidation Co and make more informed decisions for your business Gain a 360-degree view of IPI Legacy Liquidation Co and make more informed decisions for your business Register your interest
Headquarters United States of America

Address No.201, Elliott Avenue West, Suite 260, Seattle, Washington, 98119


Telephone 1 833 8783437

No of Employees 160

Industry Pharmaceuticals and Healthcare

Revenue (2022) $12.7M

   

   

Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

IPI Legacy Liquidation Co premium industry data and analytics

30+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for IPI Legacy Liquidation Co’s relevant decision makers and contact details.

17+

Clinical Trials

Determine IPI Legacy Liquidation Co go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

15+

Catalyst Calendar

Proactively evaluate IPI Legacy Liquidation Co’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

7

Pipeline Drugs

Identify which of IPI Legacy Liquidation Co’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

4

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Marketed Drugs

Understand IPI Legacy Liquidation Co’s commercialized product portfolio to stay one step ahead of the market.

1

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Products and Services

Products Brands
Trudhesa Trudhesa
Platform:
Precision Olfactory Delivery (POD) Technology
Understand IPI Legacy Liquidation Co portfolio and identify potential areas for collaboration Understand IPI Legacy Liquidation Co portfolio and identify potential areas for collaboration Register your interest
Image for loader

Competitor Comparison

Key Parameters IPI Legacy Liquidation Co OptiNose Inc AIM ImmunoTech Inc Ainos Inc Royer Biomedical Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Seattle Yardley Ocala Houston Frederick
State/Province Washington Pennsylvania Florida Texas Maryland
No. of Employees 160 127 21 44 -
Entity Type Private Private Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Executives
Name Position Board Since Age
Leonard S. Paolillo President - Interim; Chief Executive Officer Senior Management - -
John Hoekman Chief Technology and Development Officer Senior Management - -
Rigo Canal Vice President - Commercial Operations and Analytics Senior Management - -
Sarah Wille Vice President - Human Resources Senior Management - -
Scott Youmans Senior Vice President - Technical Operations Senior Management - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into IPI Legacy Liquidation Co key executives to enhance your sales strategy Gain insight into IPI Legacy Liquidation Co key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?